Viewing Study NCT02930967


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-02-21 @ 1:33 AM
Study NCT ID: NCT02930967
Status: UNKNOWN
Last Update Posted: 2016-10-12
First Post: 2016-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant Tumors
Sponsor: China Meitan General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent PD-L1+ Malignant Tumors View
None Metastatic PD-L1+ Malignant Tumors View
Keywords: